AndroDerm was originally approved for topical use in the United States in 1995 and is indicated for the replacement of testosterone in males with deficient testosterone levels. The active ingredient in AndroDerm is testosterone, which is administered through the skin in the form of a patch that the patient wears.
Since the introduction of the AndroDerm patch, some patients have filed lawsuits arguing that low-T therapy has caused serious adverse health problems. Some studies have found that testosterone therapy may be associated with heart attack, stroke and death.
If you have used this medication and suffered severe health problems as a result of AndroDerm, a lawsuit may help you recover compensation for your pain, suffering and any medical expenses.